Evidence map›Paper›PMID 28134792›Full record

ReviewVaccines2017

From Immunologically Archaic to Neoteric Glycovaccines.

Marco Cavallari, Gennaro De Libero

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Vaccines, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Glycoconjugate Vaccines for Prevention ofRussian journal of bioorganic chemistry · 2021
    Article
  2. TheThe Biochemical journal · 2019
    Review
  3. Rational Design and Evaluation of an ArtificialFrontiers in cellular and infection microbiology · 2018
    Article
  4. Article
  5. Parasite Carbohydrate Vaccines.Frontiers in cellular and infection microbiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Marco CavallariBIOSS Centre for Biological Signalling Studies, University of Freiburg, Schaenzlestrasse 18, 79104 Freiburg, Germany. marco.cavallari@bioss.uni-freiburg.de.
Gennaro De LiberoExperimental Immunology, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland. gennaro.delibero@unibas.ch.
University of Basel · CHUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polysaccharides (PS) are present in the outermost surface of bacteria and readily come in contact with immune cells. They interact with specific antibodies, which in turn confer protection from infections. Vaccines with PS from pneumococci, meningococci,

Indexed as

conjugateimmunosenescencepolysaccharideserotypeT cell helpvaccine

Identifiers

PMID28134792
PMCPMC5371740
OpenAlexW2582548096

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.